These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35004051)

  • 1. Life-Threatening Acute Chest Syndrome in a Patient With Sickle Cell Disease After Switching From Hydroxyurea Therapy to Partial Exchange Transfusions: A Case Report.
    Kvam AK; Torp HA; Iversen PO
    Cureus; 2021 Dec; 13(12):e20236. PubMed ID: 35004051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (MAGiC) study.
    Hulbert ML; Panepinto JA; Scott JP; Liem RI; Cook LJ; Simmons T; Brousseau DC;
    Transfusion; 2017 Aug; 57(8):1891-1897. PubMed ID: 28500682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Hydroxyurea Therapy in Reducing Pain Crises, Hospital Admissions, and Length of Stay Among Sickle Cell Patients in the Eastern Region of Saudi Arabia.
    Albohassan H; Ammen M; Alomran AA; Bu Shehab H; Al Sakkak H; Al Bohassan A
    Cureus; 2022 Nov; 14(11):e31527. PubMed ID: 36540486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea therapy in children severely affected with sickle cell disease.
    Scott JP; Hillery CA; Brown ER; Misiewicz V; Labotka RJ
    J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.
    Koren A; Segal-Kupershmit D; Zalman L; Levin C; Abu Hana M; Palmor H; Luder A; Attias D
    Pediatr Hematol Oncol; 1999; 16(3):221-32. PubMed ID: 10326220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Infection Presenting as Acute Chest Syndrome in a Child With Hemoglobin SD-Los Angeles Disease: A Case Report and Review of Literature.
    Calderwood S; Sabir A; Rao L; Baker B; Balasa V; Sathi BK
    J Pediatr Hematol Oncol; 2023 Mar; 45(2):82-87. PubMed ID: 36162052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of acute chest syndrome post stopping Crizanlizumab, the dilemma of stopping vs continuation in patient with sickle cell disease: case report.
    Afana MS; Abu-Tineh M; Alshurafa A; Yasin AK; Ahmed K; Abdulgayoom M; Yassin MA
    Hematology; 2023 Dec; 28(1):2229115. PubMed ID: 37519115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Painful vaso-occlusive crisis as a prodromal phase of acute chest syndrome. Is only one chest X-ray enough? A case report.
    Neocleous C; Spanou C; Adramerina A; Spyrou G; Tzanetis F
    Prague Med Rep; 2013; 114(3):180-5. PubMed ID: 24093819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute chest syndrome and COVID-19 in hydroxyurea naïve sickle cell disease patient in a low resource setting.
    Mawalla WF; Nasser A; Jingu JS; Joseph H; Mmbaga LG; Shija E; Kakumbula H; Lubuva NB; Meda C; Chamba C
    EJHaem; 2022 May; 3(2):507-512. PubMed ID: 35602245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute chest syndrome after splenectomy in children with sickle cell disease.
    Ghantous S; Al Mulhim S; Al Faris N; Abushullaih B; Shalak F; Yazbeck S
    J Pediatr Surg; 2008 May; 43(5):861-4. PubMed ID: 18485954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].
    Mellouli F; Bejaoui M
    Arch Pediatr; 2008 Jan; 15(1):24-8. PubMed ID: 18164913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.
    Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B
    EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute complications in children with sickle cell disease: Prevention and management.
    Beck CE; Trottier ED; Kirby-Allen M; Pastore Y
    Paediatr Child Health; 2022 Mar; 27(1):50-62. PubMed ID: 35273671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome.
    Yildirim N; Unal S; Yalcinkaya A; Karahan F; Oztas Y
    Ann Hematol; 2022 Jan; 101(1):35-41. PubMed ID: 34564750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.